Factors influencing length of stay, time to resolution of morbidity, and cost of patient care: A comparative retrospective study of short-stay and long-stay patients hospitalized for simple pneumonia (DRG 89 and 90)

Infectious Diseases in Clinical Practice

Volumn 10, Issue 7, 2001, Pages 375-383

  Lim, A F ^a   Tan, J S ^a   Murphy, D P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; LEVOFLOXACIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; COMORBIDITY; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; PNEUMONIA; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SHORT SURVEY;

EID: 0035680443     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200109000-00006     Document Type: Short Survey

References (30)

1. Medicare and medicaid statistical supplement, 1997
2. Pneumonia and influenza death rates - United States, 1979-1994
3. A prediction rule to identify low-risk patients with community-acquired pneumonia
4. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: An interventional trial
5. A prognostic rule for elderly patients admitted with community-acquired pneumonia
6. The hospital discharge decision for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team cohort study
7. Time to clinical stability in patients hospitalized with community-acquired pneumonia: Implications for practice guidelines
8. Community acquired pneumonia: Aetiology and usefulness of severity criteria on admission
9. Use of a treatment protocol in the management of community-acquired lower respiratory tract infection
10. Management decisions regarding community-acquired pneumonia
11. Differences in length of hospital stay in patients with community-acquired pneumonia: A prospective four-hospital study
12. Quality of care, process, and outcomes in elderly patients with pneumonia
13. A controlled trial of a critical pathway for treatment of community-acquired pneumonia
14. Community-acquired pneumonia in adults: Guidelines for management
15. Practice guidelines for the management of community-acquired pneumonia in adults
16. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
17. Economic impact of streamlining antibiotic administration
18. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia
19. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia
20. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia
21. Oral versus intravenous antibiotics for community-acquired lower respiratory infection in a general hospital: Open, randomized controlled trial
22. Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia
23. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients. A prospective, randomized, multicenter trial
24. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
25. New and emerging etiologies for community acquired pneumonia with implications for therapy
26. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pneumococcal pneumonia
27. Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients
28. Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course
29. The epidemiology of delays in a teaching hospital: The development and use of a tool that detects unnecessary hospital days
30. The hospital admission decision for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team cohort study